What is B. Riley’s Forecast for Cytokinetics Q1 Earnings?
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Equities research analysts at B. Riley issued their Q1 2025 earnings per share (EPS) estimates for shares of Cytokinetics in a report issued on Wednesday, March 5th. B. Riley analyst M. Mamtani anticipates that the biopharmaceutical company will post earnings of ($1.46) per share for the quarter. The […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Equities research analysts at B. Riley issued their Q1 2025 earnings per share (EPS) estimates for shares of Cytokinetics in a report issued on Wednesday, March 5th. B. Riley analyst M. Mamtani anticipates that the biopharmaceutical company will post earnings of ($1.46) per share for the quarter. The […]
